Point of care testing conference

7 February 2019

 5.25 CME Points Total

Dubai World Trade Centre


The development of accurate POC testing and its impact on new disease areas and disease management presents many challenges for healthcare providers but has great potential for improving patient care. At MEDLAB, integration, implementation, regulatory aspects, validation and its clinical applications will be discussed to facilitate its use.

Theme: How POCT adds value in a resource-challenged healthcare system

Key topics:

  • POCT in a value-based healthcare system
  • POCT connectivity across a network: challenges and opportunities
  • POC Creatinine – clinician’s perspective
  • Glucose monitoring and outcome measures
  • POCT and accreditation requirements
  • POCT in the ICU environment
  • POCT in the ED department
  • POCT and Coagulation Testing

Benefits of attendance

  • Evaluate how POCT adds value in a resource challenged healthcare system
  • Assess training and competency of POC professionals to comply with the latest developments in regulatory requirements and certification of POCT 
  • Discuss connectivity between POCT instruments and electronic medical records to ensure quality of results
  • Examine how implementation of POCT can improve patient outcomes, lead to advanced care and faster diagnosis 
  • Discuss how POCT can improve the quality, reliability and speed in various hospital units


Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Co Chair:
Dr Fayha Ahmed
, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA

Speaker faculty:

Anthony Cambridge, Lead Biomedical Scientist, Blood Sciences and POCT, University Hospitals  Plymouth NHS Trust, Plymouth, UK

Annette Thomas, Director, Wales External Quality Assurance Scheme, Cardiff & Vale University Health Board, Cardiff, UK

Dr Arun Kumar, Medical Director, Transplant Anesthesiology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Heba Kary, Consultant, Chemical Pathology, Department of Medical Laboratory, King Fahad Armed Forces Hospital, Jeddah, KSA

Jonathan Harris, POCT Manager, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Najwa Adlan, Medical Laboratory Supervisor, POCT, Reference Laboratory, Specimen Processing & Send Outs, Department of Pathology & Laboratory Medicine, King Faisal Specialist hospital & Research Center, Riyadh, KSA

Dr Yusra Shehadeh Othman, Senior Clinical Scientist, Clinical Chemistry - Medical Affairs, Tawam Hospital, Al Ain, UAE

Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 33.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Provided by: